原标题：中国48个城市携手青少年庆祝世界儿童日，响应"敢作气候担当"的行动 11月20日， "敢作气候担当，点亮儿童未来"世界儿童日主题活动在北京科技职业大学举行。今年 的世界儿童日主题活动聚焦于青少年从校园到国际舞台为应对气候变化所采取的积极行动。 在主题活动现场，参加了"2025年中国青少年应对气候变化倡导活动"的青少年代表分享了他们的创 新解决方案，并介绍了他们展示这些方案的经历。 11月20日， "敢作气候担当，点亮儿童未来"世界儿童日主题活动在北京科技职业大学举行。今年 的世界儿童日主题活动聚焦于青少年从校园到国际舞台为应对气候变化所采取的积极行动。 在主题活动现场，参加了"2025年中国青少年应对气候变化倡导活动"的青少年代表分享了他们的创 新解决方案，并介绍了他们展示这些方案的经历。 在世界儿童日到来之际，中国48个市县以及30多所联合国儿童基金会项目学校在联合国儿童基金会 的支持下，举办了丰富多彩、富有创意的活动，彰显了对实现儿童权利的承诺。为响应今年世界儿童日 的主题，这些市县和项目学校组织儿童青少年利用生活中产生的可回收物品创作并展示了"气候朋友"艺 术作品及手工作品，或通过其他形式的活动 ...

智通财经APP讯，粉笔(02469)公布，2025年11月21日耗资约492.01万港元回购160万股股份。 ...

其他收益及亏损由2024财年的亏损约人民币400万元大幅增加至不少于人民币2.25亿元的收益，原因是 (i)2024财年取得的于可换股债券悉数偿还后其公平值变动产生的亏损约人民币2820万元未有发生;(ii)议 价收购一间附属公司的收益，而2024财年并无此收益;及(iii)终止确认其他应付中已注销关联方款项的收 益，而2024财年并无此收益;及 有抵押银行及其他借款的利息开支减少导致2025财年的财务成本大幅减少以及2024财年悉数偿还可换股 债券导致2025财年并无产生可换股债券的利息开支。 枫叶教育(01317)发布公告，与截至2024年8月31日止年度(2024财年)相比，本集团预期于2025财年(截至 2025年8月31日止年度)取得归属于本公司拥有人的利润将不少于人民币3亿元，而2024财年则取得利润 约人民币1550万元。 根据可得资料，董事会认为利润大幅增加的主要原因是： ...

其他收益及亏损由2024财年的亏损约人民币400万元大幅增加至不少于人民币2.25亿元的收益，原因是 (i) 2024财年取得的于可换股债券悉数偿还后其公平值变动产生的亏损约人民币2820万元未有发生;(ii)议 价收购一间附属公司的收益，而2024财年并无此收益;及(iii)终止确认其他应付中已注销关联方款项的收 益，而2024财年并无此收益;及 有抵押银行及其他借款的利息开支减少导致2025财年的财务成本大幅减少以及2024财年悉数偿还可换股 债券导致2025财年并无产生可换股债券的利息开支。 智通财经APP讯，枫叶教育(01317)发布公告，与截至2024年8月31日止年度(2024财年)相比，本集团预 期于2025财年(截至2025年8月31日止年度)取得归属于本公司拥有人的利润将不少于人民币3亿元，而 2024财年则取得利润约人民币1550万元。 根据可得资料，董事会认为利润大幅增加的主要原因是： ...

Core Points - The internal letter from Yu Minhong, founder of New Oriental, has sparked significant public backlash due to its perceived disconnect from employee concerns, particularly regarding work pressure and long hours [3][20] - Despite the controversy, New Oriental's stock price rose by 2.75% to $53.44 on the first trading day after the letter, although the stock has dropped 16.2% year-to-date and over 70% from its peak of $198.54 in 2021 [3][20] - New Oriental's net profit has plummeted by 73.7%, highlighting the company's financial struggles amid a talent crisis following the departure of key figures like Dong Yuhui and others [4][16] Company Overview - New Oriental has launched a new cultural tourism brand, aiming to diversify its business and leverage its existing educational resources [11][12] - The cultural tourism division has already established over 100 travel routes across 23 provinces, targeting K12 and university students [12] - The company reported a revenue of 3.3 billion yuan in 2023 for its tourism segment, with plans to expand into new areas such as cultural IP and hotel management [12] Financial Performance - For the fourth quarter of the 2025 fiscal year, New Oriental reported revenues of $1.24 billion, a year-on-year increase of 9.4%, but a net profit of only $710,000, down 73.7% [16] - The significant drop in net profit is attributed to rising costs, including a record goodwill impairment of $60.3 million [16] - The performance of Dong Yuhui's new venture, "With Hui Tongxing," has negatively impacted the sales and viewership of New Oriental's live-streaming business [19] Talent and Leadership Challenges - The departure of key influencers like Dong Yuhui has led to a strategic shift towards "de-IP" to reduce reliance on individual personalities [13][14] - The company is facing challenges in maintaining its competitive edge in the live-streaming e-commerce sector due to the loss of its star hosts [18][19] - New Oriental's leadership is attempting to adapt by focusing on building a more sustainable operational model rather than depending on high-profile individuals [13][14]

Core Viewpoint - The company, Zhonggong Education, is expanding its strategic layout by establishing a wholly-owned subsidiary in the Hengqin Guangdong-Macao Deep Cooperation Zone to enhance business collaboration in the Greater Bay Area [1] Group 1 - The subsidiary, Beijing Zhonggong Zhiyuan Technology Co., Ltd., plans to set up a new entity named Zhonggong Zhiyuan (Zhuhai Hengqin) Education Technology Co., Ltd. with a registered capital of 150 million yuan [1] - This move aims to accelerate the expansion into the South China market and promote the company's sustainable development [1]

应对即将于明年达峰的初中学龄人口和即将于2029年达峰的高中阶段学龄人口，加大教育资源的调配十 分关键。 《中共中央关于制定国民经济和社会发展第十五个五年规划的建议》（下称《建议》）提出，健全与人 口变化相适应的教育资源配置机制。近期出版发行的《党的二十届四中全会〈建议〉学习辅导百问》一 书中，对"怎样理解健全与人口变化相适应的教育资源配置机制"作出了详细解读。 其中，解读文章指出，加强跨学段动态调整和余缺调配。教育资源调配必须统筹考虑不同学段波峰前的 较大压力和波峰后的相对缓解，通过资源贯通衔接提高使用效益。要推动地方加强近期和中长期教育资 源统筹配置，全面打通县域内小学和初中校舍资源共享途径，因地制宜支持有条件的义务教育学校和普 通高中就近共享校舍。对于新建义务教育学校，鼓励探索按照普通高中有关标准建设，为学龄人口变化 后优化调整预留空间。 另一方面，近几年普通高中招生人数持续增长。其中，2021年首次突破900万人大关，2024年首次突破 千万大关。2024年普高录取率首次突破六成，达到了61.02%。 小学在校生规模已在达峰，初中阶段预计明年达峰，高中阶段将在2029年达峰。 近年来，出生人口变化对教 ...

人民网陵水11月21日电 （记者宋歌、陈思）走进海南陵水黎安国际教育创新试验区，最引人注目 的莫过于坐落于海滨的图书馆。这座由园区内各大高校师生共享的服务建筑，不仅为校园生活增添一抹 亮色，也体现了试验区"大共享+小学院"的创新教育理念：公共设施共享使用，各高校使用专享小学 院，通过"大共享平台"促进中外互鉴、学科互融、文理互通、课程互选、学分互认、管理共商。 这片由教育部和海南省共建的试验区，是海南自贸港中唯一以教育对外开放为核心使命的园区。目 前园区内签约入驻国内外高校26所，累计培养留学生一千余人。依托海南自贸港优势，通过人才机制创 新，海南陵水黎安国际教育试验区正向国内外人才展现出日益增长的吸引力。 ...

（文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：贵公司在AI教育方面取得哪些实质性推广成果，目前 市场反应如何？与AI相关的收益取得多大增长？对公司后续业绩的年增长率预计有多大？ 世纪天鸿（300654.SZ）11月21日在投资者互动平台表示，公司以教辅图书为核心业务，近年来积极推 动"AI+教育"第二曲线业务落地。"小鸿助教"作为公司基于大语言模型自主研发的教师端助教产品，致 力于实现教育内容的人工智能升级。近日，"小鸿助教"携手北师大，作为国家重点双课题研究成果，受 邀亮相于11月15日—17日在广东珠海举办的教博会北京师范大学展区，作为首个支持核心素养教案生成 的平台，在AI赋能教育的新时代具有尝试、探索的引领性和开启性意义，受到了不少市场和一线教师 的关注。目前，"小鸿助教"等产品已在部分区域和学校开展应用，商业化路径正按计划推进中，后续业 务进展请您关注公司披露的定期报告。 ...

Investment Rating - The report maintains a positive outlook on the overseas pharmaceutical sector, particularly focusing on innovative drugs and industry chain opportunities, with an investment rating of "Overweight" [1][6]. Core Insights - Multiple policies are supporting the development of the innovative drug industry, with domestic innovative drug transactions reaching historical highs in both value and quantity. The sector's valuation has rebounded from a low point, and leading companies are achieving profitability through increased commercial sales and licensing income [6][8]. - Companies like BeiGene are experiencing significant growth, with global sales exceeding $1 billion in Q3 2025, marking a 51% year-on-year increase. The company anticipates a positive GAAP operating profit for the full year 2025, raising its revenue guidance to $5.1-5.3 billion [1][6]. - Innovent Biologics is expanding its pipeline with a dual focus on oncology and non-oncology products, expecting to achieve positive non-IFRS net profit and EBITDA in 2024, with continued growth projected for 2025 [2][6]. - The report highlights the increasing R&D investments by leading pharmaceutical companies, which are enhancing their innovative pipelines and accelerating their transformation towards innovation [3][7]. Summary by Sections Section 1: Overseas Pharmaceuticals - The report emphasizes the focus on innovative drugs and the opportunities within the industry chain for 2026, noting the historical highs in transaction amounts and numbers for domestic innovative drugs going overseas [6][8]. - BeiGene's overseas sales are highlighted, with Q3 2025 global sales surpassing $1 billion and a significant year-on-year profit turnaround [1][6]. - Innovent Biologics is noted for its strategic partnerships and expected profitability in the coming years [2][6]. Section 2: Pharma Sector - Leading companies are rapidly increasing their R&D investments, which is expected to strengthen their innovative pipelines and global competitiveness [3][7]. - Companies like Hansoh Pharmaceutical and China Biologic Products are projected to see substantial growth in their innovative product revenues, with significant contributions expected in the coming years [3][7]. Section 3: CXO Sector - The report indicates a recovery in investment and financing for innovative drugs, which is likely to drive early-stage R&D investments and boost demand [8]. - Emerging fields such as peptides and ADCs are expected to open new growth opportunities, with a recommendation to focus on companies like WuXi AppTec and WuXi Biologics [8].